vvDD-hIL2-RG-1

AXP000098.2 · Oncolytic virus

Platform
vaccinia virus (Western Reserve, TK- VGF-)
Originator
University of Pittsburgh
Sponsor
Allegheny Health Network Research Institute

Names

NameTypeSource
vvDD-hIL2-RG-1preferred name, codecurator, ctgov
vvDD-hIL2-2-RG-1synonymctgov

Virus

Role
Oncolytic
Family
Poxviridae
Virus
vaccinia virus (NCBI Taxonomy 10245)
Strain
Western Reserve
Replication
conditionally replicating
Modifications
J2R (thymidine kinase) and vaccinia growth factor deleted
Transgenes
IL2 (matrix-anchored)
Route
intratumoral
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07001592Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal TumorsRecruitingPhase 12025-05-062028-0418Esophageal Cancer; Gastric Adenocarcinoma; Gastric Cancer; Gastric Neoplasms; Liver Cancer; Liver Metastasis; MSI-H; MSS; MSS-CRC; Peritoneal Cancer; Peritoneal Carcinoma; Peritoneal Metastases

Recent changes

No changes recorded in its trials yet.

Notes

Double-deleted vaccinia carrying a tumour-matrix-anchored human IL-2; phase 1 by intratumoral injection in gastrointestinal and peritoneal tumours (NCT07001592, recruiting since June 2025). Dosing of at least one patient inferred from the recruiting status, not confirmed by a report.

How to cite

vvDD-hIL2-RG-1 (AXP000098.2). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000098.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.